LDHA/PDKs-IN-1 is a potent dual inhibitor of PDKs and LDHA with IC50 values of 0.8 and 0.15 μM, respectively; it reduces A549 cell proliferation (EC50 = 13.2 μM), decreases lactate production, increases oxygen consumption, and shows potential for cancer research.